Search results
BioNTech SE (NASDAQ:BNTX) Shares Sold by First Trust Advisors LP
ETF DAILY NEWS· 6 hours agoFirst Trust Advisors LP lowered its position in BioNTech SE (NASDAQ:BNTX – Free Report) by 0.6% in the fourth quarter, according to the company in its most recent Form 13F ...
BioNTech SE (NASDAQ:BNTX) Receives $111.70 Average Target Price from Analysts
ETF DAILY NEWS· 1 day agoShares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been given an average rating of “Hold” by the ten ratings firms that are currently covering the firm, MarketBeat.com ...
BioNTech doubles down on ADC partner MediLink in new $1.8B biobucks pact
Endpoints News· 2 weeks agoAs BioNTech’s pipeline tilts back toward oncology, the German biotech is once again tapping a young...
BioNTech gets $145 million funding for African vaccine plants
Reuters via AOL· 2 weeks agoFRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 4 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
BioNTech and CEPI expand deal to boost Africa’s vaccine capabilities
Pharmaceutical Technology via Yahoo Finance· 1 week agoBioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced an expansion...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 4 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC
Clinical Trials Arena via Yahoo Finance· 6 days agoGenmab and BioNTech announced the initial data from the phase II GCT1046-04 trial, which evaluated...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 weeks agoMediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership PR Newswire SUZHOU ...
BioNTech wins up to $145 mln in CEPI support for African mRNA vaccine plants
Reuters· 2 weeks agoCOVID-19 vaccine maker BioNTech won up to $145 million in funding from a global coalition against...